334 related articles for article (PubMed ID: 26087476)
1. CRISPR/Cas9-mediated gene knockout of NANOG and NANOGP8 decreases the malignant potential of prostate cancer cells.
Kawamura N; Nimura K; Nagano H; Yamaguchi S; Nonomura N; Kaneda Y
Oncotarget; 2015 Sep; 6(26):22361-74. PubMed ID: 26087476
[TBL] [Abstract][Full Text] [Related]
2. Activated 5'flanking region of NANOGP8 in a self-renewal environment is associated with increased sphere formation and tumor growth of prostate cancer cells.
Zhang K; Fowler M; Glass J; Yin H
Prostate; 2014 Apr; 74(4):381-94. PubMed ID: 24318967
[TBL] [Abstract][Full Text] [Related]
3. NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation.
Jeter CR; Liu B; Liu X; Chen X; Liu C; Calhoun-Davis T; Repass J; Zaehres H; Shen JJ; Tang DG
Oncogene; 2011 Sep; 30(36):3833-45. PubMed ID: 21499299
[TBL] [Abstract][Full Text] [Related]
4. NANOG modulates stemness in human colorectal cancer.
Zhang J; Espinoza LA; Kinders RJ; Lawrence SM; Pfister TD; Zhou M; Veenstra TD; Thorgeirsson SS; Jessup JM
Oncogene; 2013 Sep; 32(37):4397-405. PubMed ID: 23085761
[TBL] [Abstract][Full Text] [Related]
5. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
6. Reprogramming activity of NANOGP8, a NANOG family member widely expressed in cancer.
Palla AR; Piazzolla D; Abad M; Li H; Dominguez O; Schonthaler HB; Wagner EF; Serrano M
Oncogene; 2014 May; 33(19):2513-9. PubMed ID: 23752184
[TBL] [Abstract][Full Text] [Related]
7. Nanog interaction with the androgen receptor signaling axis induce ovarian cancer stem cell regulation: studies based on the CRISPR/Cas9 system.
Ling K; Jiang L; Liang S; Kwong J; Yang L; Li Y; PingYin ; Deng Q; Liang Z
J Ovarian Res; 2018 May; 11(1):36. PubMed ID: 29716628
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of nanog1 and nanogp8 in colon cancer cells.
Ishiguro T; Sato A; Ohata H; Sakai H; Nakagama H; Okamoto K
Biochem Biophys Res Commun; 2012 Feb; 418(2):199-204. PubMed ID: 22079639
[TBL] [Abstract][Full Text] [Related]
9. Human Nanog pseudogene8 promotes the proliferation of gastrointestinal cancer cells.
Uchino K; Hirano G; Hirahashi M; Isobe T; Shirakawa T; Kusaba H; Baba E; Tsuneyoshi M; Akashi K
Exp Cell Res; 2012 Sep; 318(15):1799-807. PubMed ID: 22677041
[TBL] [Abstract][Full Text] [Related]
10. NANOGP8 is a retrogene expressed in cancers.
Zhang J; Wang X; Li M; Han J; Chen B; Wang B; Dai J
FEBS J; 2006 Apr; 273(8):1723-30. PubMed ID: 16623708
[TBL] [Abstract][Full Text] [Related]
11. Targeted delivery of CRISPR/Cas9 to prostate cancer by modified gRNA using a flexible aptamer-cationic liposome.
Zhen S; Takahashi Y; Narita S; Yang YC; Li X
Oncotarget; 2017 Feb; 8(6):9375-9387. PubMed ID: 28030843
[TBL] [Abstract][Full Text] [Related]
12. RNase L is a negative regulator of cell migration.
Banerjee S; Li G; Li Y; Gaughan C; Baskar D; Parker Y; Lindner DJ; Weiss SR; Silverman RH
Oncotarget; 2015 Dec; 6(42):44360-72. PubMed ID: 26517238
[TBL] [Abstract][Full Text] [Related]
13. Single-step generation of gene knockout-rescue system in pluripotent stem cells by promoter insertion with CRISPR/Cas9.
Matsunaga T; Yamashita JK
Biochem Biophys Res Commun; 2014 Feb; 444(2):158-63. PubMed ID: 24462858
[TBL] [Abstract][Full Text] [Related]
14. ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts.
Valletta S; Dolatshad H; Bartenstein M; Yip BH; Bello E; Gordon S; Yu Y; Shaw J; Roy S; Scifo L; Schuh A; Pellagatti A; Fulga TA; Verma A; Boultwood J
Oncotarget; 2015 Dec; 6(42):44061-71. PubMed ID: 26623729
[TBL] [Abstract][Full Text] [Related]
15. Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells.
Ambady S; Malcuit C; Kashpur O; Kole D; Holmes WF; Hedblom E; Page RL; Dominko T
Int J Dev Biol; 2010; 54(11-12):1743-54. PubMed ID: 21136380
[TBL] [Abstract][Full Text] [Related]
16. Androgen/androgen receptor axis maintains and promotes cancer cell stemness through direct activation of Nanog transcription in hepatocellular carcinoma.
Jiang L; Shan J; Shen J; Wang Y; Yan P; Liu L; Zhao W; Xu Y; Zhu W; Su L; Chen J; Cheng F; Yao H; Xu H; Qian C; Liang Z
Oncotarget; 2016 Jun; 7(24):36814-36828. PubMed ID: 27167111
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9 targeting of the androgen receptor suppresses the growth of LNCaP human prostate cancer cells.
Wei C; Wang F; Liu W; Zhao W; Yang Y; Li K; Xiao L; Shen J
Mol Med Rep; 2018 Feb; 17(2):2901-2906. PubMed ID: 29257308
[TBL] [Abstract][Full Text] [Related]
18. NANOGP8: evolution of a human-specific retro-oncogene.
Fairbanks DJ; Fairbanks AD; Ogden TH; Parker GJ; Maughan PJ
G3 (Bethesda); 2012 Nov; 2(11):1447-57. PubMed ID: 23173096
[TBL] [Abstract][Full Text] [Related]
19. Generation of PTEN‑knockout (‑/‑) murine prostate cancer cells using the CRISPR/Cas9 system and comprehensive gene expression profiling.
Takao A; Yoshikawa K; Karnan S; Ota A; Uemura H; De Velasco MA; Kura Y; Suzuki S; Ueda R; Nishino T; Hosokawa Y
Oncol Rep; 2018 Nov; 40(5):2455-2466. PubMed ID: 30226608
[TBL] [Abstract][Full Text] [Related]
20. [The expression of retrogene Nanogp8 is related to the biological characteristics of human SGC-7901 gastric cancer cells].
Liu Y; Wang C; Jiang Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jun; 31(6):763-8. PubMed ID: 26062418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
